West Pharmaceutical Services (WST) Prepaid Assets (2009 - 2026)

West Pharmaceutical Services has disclosed Prepaid Assets across 18 years of filings, most recently posting $167.2 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $167.2 million, up 38.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $167.2 million (up 38.18% YoY), and the FY2025 annual result was $168.6 million, up 35.97% from the prior year.
• Prepaid Assets came in at $167.2 million for Q1 2026 at West Pharmaceutical Services, down from $168.6 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $168.6 million in Q4 2025 to a low of $90.5 million in Q1 2023.
• The 5-year median for Prepaid Assets is $124.0 million (2024), against an average of $127.2 million.
• Across the five-year window, Prepaid Assets soared 59.64% in 2022 and decreased 16.43% in 2023, its largest moves.
• West Pharmaceutical Services' Prepaid Assets stood at $103.0 million in 2022, then jumped by 31.84% to $135.8 million in 2023, then retreated by 8.69% to $124.0 million in 2024, then surged by 35.97% to $168.6 million in 2025, then fell by 0.83% to $167.2 million in 2026.
• The last three Prepaid Assets figures came in at $167.2 million (Q1 2026), $168.6 million (Q4 2025), and $131.8 million (Q3 2025), per Business Quant data.